Biogen’s market value has risen by $45 billion to nearly $110 billion in a little over a year

An experimental Alzheimer’s drug being developed by a US biotech group has offered hope that scientists may be closer to a breakthrough for the devast(...)

Denis Naughten, TD, believes Ireland should be a pilot country for State-funded multiple sclerosis drug. Photograph: Dara Mac Dónaill

The Health Service Executive has rejected a second application from the makers of a drug that helps people with multiple sclerosis to walk to have it(...)

Minister of State at the Department of Health Kathleen Lynch says Biogen’s new application is being assessed. Photograph: Eric Luke / The Irish Times

The makers of a drug that helps people with multiple sclerosis to walk have made a new application to have it covered by the Health Service Executi(...)

Although Fampridine, known commercially as Fampyra, is not covered by Health Service Executive-funded drug schemes, it has been provided free to patients for the past 2½ years under a clinical trial by the manufacturer, Biogen. Photograph: Biogen

Multiple sclerosis patients will have to pay up to €400 per month from today for a drug to improve mobility which was previously provided free of char(...)

Minister of State for Primary Care Alex White: said Biogen had told the HSE it intended to submit a revised application to the NCPE. Photograph: Alan Betson/The Irish Times

The makers of a drug that helps people with multiple sclerosis to walk are to make a fresh application to have it covered by the Health Service Execu(...)

The curve of the German share price index DAX board is pictured at the Frankfurt stock exchange. Photograph: Reuters/Fabrizio Bensch

A boost for mining companies and Sky Deutschland helped drive European stocks rose to their highest level in more than six years. Commodity produce(...)

Netflix continued its downward trend, slipping 1.6 per cent to $358.50.

Stocks rose yesterday as data emerged showing confidence is up in a number of European economies and in the US. Traders (...)

The  front of the European Central Bank  headquarters in Frankfurt, Germany: the ECB  has kept its benchmark interest rate unchanged at a record low 0.25 per cent

Tom Lyons Senior Business Correspondent European stocks were little changed, paring earlier gains, after the European Central Bank kept i(...)

Perrigo  president and chief executive Joe Papa. Photograph: Brenda Fitzsimons

In a statement, Perrigo said it had done a deal with Canadian group Transition Therapeutics, the partner in the ELND005 programme(...)

Biogen Idec said today its new, high-profile oral multiple sclerosis drug Tecfidera had sales of $398 million in the fourth quarter, easily exceeding (...)